BCB
IONS icon

Brian C. Broderick’s Ionis Pharmaceuticals IONS Stock Holding History

Brian C. Broderick’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-18,666
Closed -$750K – 97
2017
Q1 		$750K Sell
18,666
-3,575
-16% -$161K 0.31% 59
2016
Q4 		$1.06M Sell
22,241
-400
-2% -$15.8K 0.46% 54
2016
Q3 		$829K Sell
22,641
-1,803
-7% -$56.4K 0.35% 55
2016
Q2 		$570K Buy
24,444
+4,949
+25% +$160K 0.24% 68
2016
Q1 		$788K Buy
19,495
+335
+2% +$13.6K 0.34% 59
2015
Q4 		$1.19M Buy
19,160
+1,253
+7% +$67.6K 0.53% 60
2015
Q3 		$723K Buy
17,907
+2,250
+14% +$116K 0.33% 64
2015
Q2 		$902K Hold
15,657
– – 0.38% 64
2015
Q1 		$997K Hold
15,657
– – 0.41% 62
2014
Q4 		$967K Buy
15,657
+1,048
+7% +$51.7K 0.41% 62
2014
Q3 		$567K Buy
14,609
+1,156
+9% +$41K 0.25% 71
2014
Q2 		$464K Buy
+13,453
New +$424K 0.21% 74

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Brian C. Broderick's IONS Position: Q2 2017 in Review

Brian C. Broderick sold out of Ionis Pharmaceuticals (IONS) in Q2 2017, closing a stake of 18,666 shares — an estimated $750K sold.

Brian C. Broderick first reported a position in IONS in Q2 2014 and held it in 12 quarters. The position peaked at $1.19M in Q4 2015. 293 funds tracked by Wall St. Rank hold IONS as of Q2 2017.

  • Brian C. Broderick reported no remaining Ionis Pharmaceuticals position as of Q2 2017 after selling out during the quarter.
  • Brian C. Broderick sold 18,666 Ionis Pharmaceuticals shares in Q2 2017, an estimated $750K.
  • Brian C. Broderick first reported a position in Ionis Pharmaceuticals in Q2 2014 and held it in 12 quarters.
  • Brian C. Broderick's Ionis Pharmaceuticals position peaked at $1.19M in Q4 2015.
  • 293 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2017.

Based on Brian C. Broderick's 13F filing for Q2 2017, filed 21 Jul 2017.